Chemical composition of smectite-bearing basal metalliferous sediments from DSDP Leg 9

The mineralogy and P, Fe and Mn contents of basal metalliferous and nonmetalliferous sediments of two Deep Sea Drilling Project cores (Sites 77 and 80) were investigated. When compared with superjacent nonmetalliferous material, basal metalliferous sediments are significantly enriched in P, Fe and Mn. Among the phases present in the metalliferous sediment samples are a poorly-crystalline Fe-rich smectite and X-ray amorphous Fe oxyhydroxides. P is associated primarily with the oxyhydroxides. Adsorption of phosphate on smectite does not seem to play any role in the uptake of P by metalliferous sediments. An estimate of the removal of P by on- and off-ridge metallogenic deposition suggests that this process strongly affects the overall geochemical balance of phosphorus in the World Ocean.

(Table 1) Composition of basal sediments collected during DSDP Leg 16

Iron-rich sediments chemically similar to those forming at present on the crest of the East Pacific Rise have been found just above basement at widely separated drill sites in the eastern equatorial Pacific, including three sites of Leg 16 of the Deep Sea Drilling Project. These sediments were probably formed when the basement was at the crest of this rise and have moved to their present location as a result of sea-floor spreading.

Preliminary delineation and description of the regional aquifers of Tennessee--Basal sandstone west of the Valley and Ridge Province / by J.V. Brahana ... [et al.] ; prepared in cooperation with the U.S. Environmental Protection Agency ; [prepared by U.S. Geological Survey].

Shipping list no.: 86-886-P.

Basal metabolism in health and disease.

Bibliographical foot-notes.

Basal metabolism in health and disease.

Bibliographical footnotes.

Quantifying ice-shelf basal melt and ice-stream dynamics using high-resolution DEM and GPS time series

Thesis (Ph.D.)--University of Washington, 2016-06

Synaptology of the proximal segment of pyramidal cell basal dendrites

Pyramidal neurons are covered with dendritic spines, the main postsynaptic targets of excitatory (asymmetrical) synapses. However, the proximal portion of both the apical and basal dendrites is devoid of spines, suggesting a lack of excitatory inputs to this region. In the present study we used electron microscopy to analyse the proximal region of the basal dendrites of supra- and infragranular pyramidal cells to determine if this is the case. The proximal region of 80 basal dendrites sampled from the rat hindlimb representation in the primary somatosensory cortex was studied by electron microscopy A total of 317 synapses were found within this region of the dendrites, all of which were of the symmetrical type. These results suggest that glutamate receptors, although present in the cytoplasm, are not involved in synaptic junctions in the proximal portion of the dendrites. These data further support the idea that inhibitory terminals exclusively innervate the proximal region of basal dendrites.

The effect of skin examination surveys on the incidence of basal cell carcinoma in a Queensland community sample: A 10-year longitudinal study

Skin cancers pose a significant public health problem in high-risk populations. We have prospectively monitored basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) incidence in a Queensland community over a 10-y period by recording newly treated lesions, supplemented by skin examination surveys. Age-standardized incidence rates of people with new histologically confirmed BCC were 2787 per 100,000 person-years at risk (pyar) among men and 1567 per 100,000 pyar among women, and corresponding tumor rates were 5821 per 100,000 pyar and 2733 per 100,000 pyar, respectively. Incidence rates for men with new SCC were 944 per 100,000 pyar and for women 675 per 100,000 pyar; tumor rates were 1754 per 100,000 pyar and 846 per 100,000 pyar, respectively. Incidence rates of BCC tumors but not SCC tumors varied noticeably according to method of surveillance, with BCC incidence rates based on skin examination surveys around three times higher than background treatment rates. This was mostly due to an increase in diagnosis of new BCC on sites other than the head and neck, arms, and hands associated with skin examination surveys and little to do with advancing the time of diagnosis of BCC on these sites as seen by a return to background rates following the examination surveys. We conclude that BCC that might otherwise go unreported are detected during skin examination surveys and thus that such skin cancer screening can influence the apparent burden of skin cancer.

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

Purpose: To investigate the proportion of breast cancers arising inpatients with germ line BRCA1 and BRCA2 mutations expressing basal markers and developing predictive tests for identification of high-risk patients. Experimental Design: Histopathologic material from 182 tumors in BRCA1 mutation carriers, 63 BRCA2 carriers, and 109 controls, collected as part of the international Breast Cancer Linkage Consortium were immunohistochemically stained for CK14, CK5/6, CK17, epidermal growth factor receptor (EGFR), and osteonectin. Results: All five basal markers were commoner in BRCA1 tumors than in control tumors (CK14: 61% versus 12%; CK5/6: 58% versus 7%; CK17: 53% versus 10%; osteonectin: 43% versus 19%; EGFR: 67% versus 21%; P < 0.0001 in each case). In a multivariate analysis, CK14, CK5/6, and estrogen receptor (ER) remained significant predictors of BRCA1 carrier status. In contrast, the frequency of basal markers in BRCA2 tumors did not differ significant from controls. Conclusion: The use of cytokeratin staining in combination with ER and morphology provides a more accurate predictor of BRCA1 mutation status than previously available, that may be useful in selecting patients for BRCA1 mutation testing. The high percentage of BRCA1 cases positive for EGFR suggests that specific anti-tyrosine kinase therapy may be of potential benefit in these patients.